ArticleDiscover nano2026
Green synthesis of silver nanoparticles from Elaeagnus angustifolia extract: characterization and evaluation of antibacterial and cytotoxic properties.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCurrent medical problems are complex and require a new approach. Nanomaterials can address these complications. Silver nanoparticles (AgNPs), in particular green-synthetized particles, because of their unique properties have attract the attention of scientist. The objective of this work deals with using Elaeagnus angustifolia (EA) leaf extract as a reducing agent for biofabrication of AgNPs and investigation of its antibacterial and anti-cancer properties.
methodUV-Visible spectroscopy (UV-Vis), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), field emission scanning electron microscopy (FESEM), transmission Electron Microscopy (TEM), Scanning-Transmission Electron Microscope (STEM) and atomic force microscopy (AFM) techniques were used for characterization of the biosynthesized AgNPs. Antimicrobial efficacy was measured through disk diffusion and minimum inhibitory concentration (MIC) methods, while cytotoxic effects on PC-3 cancer cells were evaluated using the MTT assay.
resultThe biosynthesized AgNPs exhibited a strong surface plasmon resonance peak at approximately 441 nm, confirming successful synthesis. XRD analysis indicated a face-centered cubic structure, with crystallite sizes 27.04 nm. Antibacterial tests revealed significant activity against E. coli and K. pneumoniae, with AgNPs demonstrating comparable efficacy to standard antibiotics. In particular, AgNPs demonstrated successful activity on E. coli with an MIC value of 113.24 ± 14.36 and an inhibition zone of 24.32 ± 1.25 mm, comparable to standard antibiotics Furthermore, the AgNPs displayed notable cytotoxic effects on PC-3 cells, with an IC
conclusionThe results explore the potential of leaf extract of Elaeagnus angustifolia as an effective agent for the green synthesis of AgNPs that have significant antibacterial properties. This study supports the application of green synthesis in medical therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.